IMMUNEONCO-B (01541) issued 24.2 million shares for sale.
Ying Ming-likang Co.-B (01541) announces that on October 16, 2025, the company, pursuant to the general authorization and...
IMMUNEONCO-B (01541) announced that on October 16, 2025, the company issued and distributed 24.2 million new H shares in accordance with the general authorization and the placement agreement dated October 9, 2025.
Related Articles
Key points of the Securities Morning Meeting | The "anti-inward spiral" of the photovoltaic industry has become the core contradiction in the current industry. Optimistic about the direction of new technological iteration.
CITIC SEC: It is expected that the size of bank wealth management in October will exceed one trillion yuan, and the annual peak is expected to reach over 3.35 trillion yuan.
Beijing Aosaikang Pharmaceutical's subsidiary signs ASKG712 project authorization license agreement.
Key points of the Securities Morning Meeting | The "anti-inward spiral" of the photovoltaic industry has become the core contradiction in the current industry. Optimistic about the direction of new technological iteration.
CITIC SEC: It is expected that the size of bank wealth management in October will exceed one trillion yuan, and the annual peak is expected to reach over 3.35 trillion yuan.
Beijing Aosaikang Pharmaceutical's subsidiary signs ASKG712 project authorization license agreement.
RECOMMEND
